Introduction
Macrophages are responsible for the maintenance of tissue homeostasis and for orchestrating defence responses and healing processes in adult tissues (Hume, 2006) . One of the major functions of macrophages is the clearance of exogenous non-self as well as unwanted-self components present in the extracellular environment. The selectivity of ligand recognition is a result of a highly specific pattern of scavenger receptor expression by resident tissue macrophages and by newly recruited monocytes undergoing differentiation to macrophages (Gordon, 2002) . A distinction between apoptotic cells (unwanted-self) and microbial pathogens (non-self) must be made because the clearance of apoptotic cells by phagocytes occurs in the absence of inflammatory responses (Savill et al., 2002) . Various subpopulations of alternatively activated (M2) macrophages express molecular repertoires leading to tolerance and the resolution of inflammation, and display a high phagocytic capacity . Using our in vitro model for alternatively activated macrophages we demonstrated that combination of interleukin-4 (IL-4) and dexamethasone stimulates the phagocytic capacity of macrophages and induces expression of scavenger receptors including CD163, MARCO, and stabilin-1 Kzhyshkowska et al., 2006c; Politz et al., 2002) . In vivo stabilin-1 is expressed by cells specialized in the clearance of unwanted-self and in the maintenance of tissue homeostasis, including different subsets of tissue macrophages as well as non-continuous endothelial cells in lymph nodes, liver, spleen and bone marrow (Goerdt et al., 1993; Goerdt and Orfanos, 1999; Martens et al., 2006; Politz et al., 2002) .
Stabilin-1 (also called FEEL-1 and CLEVER-1) and stabilin-2 (also called FEEL-2 and HARE) are type I transmembrane receptors with multiple functions (Kzhyshkowska et al., 2006a) . They were initially identified as high molecular weight proteins produced by sinusoidal endothelial cells and have been reported to function as scavenger receptors. These proteins affect the endocytosis of acetylated low-density lipoprotein (acLDL) and advanced glycation end products (AGE) and have binding activities with Gramnegative and Gram-positive bacteria (Adachi and Tsujimoto, 2002; Kzhyshkowska et al., 2005; Tamura et al., 2003) . They have also been reported to contribute to the endothelial adhesion of lymphocytes (Irjala et al., 2003; Jung et al., 2007; Salmi et al., 2004) . Although stabilin-1 shares common features with stabilin-2, its function appears to be significantly different from that of stabilin-2. For example, while stabilin-2 efficiently mediates the uptake of hyaluronic acid (HA) and AGE-modified proteins, stabilin-1 does not bind HA and binds AGE-modified proteins with a lower affinity. A recent study reported that stabilin-1 mediates the internalization Stabilin-1 is specifically expressed in alternatively activated macrophages. These macrophages participate in antiinflammatory and healing processes, and display a high phagocytic capacity. In this study, we provide evidence that stabilin-1 is a membrane receptor that performs a crucial function in the clearance of cell corpses. Stabilin-1 is expressed on the cell surface of alternatively activated macrophages and is recruited to the sites of recognition and engulfment of apoptotic bodies, as well as to early phagosomes. Blocking stabilin-1 in macrophages results in defective engulfment of aged red blood cells. Ectopic expression of stabilin-1 induces the binding and engulfment of aged cells in mouse fibroblast L cells. The binding and phagocytosis are dependent on phosphatidylserine (PS), which is well known as an engulfing ligand. Furthermore, using PS-coated beads, we demonstrate that PS directly interacts with stabilin-1 and is sufficient for stabilin-1-mediated phagocytosis. EGF-like domain repeat in stabilin-1 is responsible for PS recognition and binding. Thus, our results demonstrate that stabilin-1, found on alternatively activated macrophages, is a phagocytic receptor mediating the clearance of apoptotic cells in a PS-dependent manner. Therefore, this protein might play an important role in the maintenance of tissue homeostasis and prevention of autoimmunity.
and clearance of SPARC (secreted protein acidic and rich in cysteine), a multifunctional regulator of tissue remodeling (Kzhyshkowska et al., 2006c) . These data lead to the proposal that stabilin-1 in alternatively activated macrophages can actively regulate unwanted self content in the extracellular matrices and spaces. In addition to functioning as a scavenger receptor, stabilin-1 in macrophages is involved in intracellular sorting and lysosomal delivery of the novel stabilin-1-interacting chitinase-like protein (SI-CLP) (Kzhyshkowska et al., 2006b) . Furthermore, in alternatively activated macrophages stabilin-1 internalizes hormone placental lactogen and targets part of it for degradation in lysosomes and part to a novel trans-Golgi-network-mediated transcytosis (Kzhyshkowska et al., 2008) .
The efficient removal of cell corpses is crucial to the protection of normal healthy cells from the harmful contents and debris of dying cells, thereby reducing the amount of tissue damage that occurs as a result of inappropriate inflammation or autoimmune responses (Ravichandran and Lorenz, 2007; Savill and Fadok, 2000) . Phagocytes mediate the clearance of apoptotic cells through the recognition of phosphatidylserine (PS) on the cell surface (Erwig and Henson, 2008; Wu et al., 2006) . Recently, Tim4 and BAI1 were suggested as novel members of a PS-receptor (Miyanishi et al., 2007; Park et al., 2007) . More recently, we demonstrated that stabilin-2 is a PS-receptor that mediates the clearance of cell corpses (Park et al., 2008a) . Although endocytic ligands of stabilin-1 are different from those of stabilin-2, stabilin-1 is specifically expressed in alternatively activated macrophages that actively participate in anti-inflammatory and healing processes. These macrophages also display a high phagocytic capacity, suggesting that stabilin-1 could also participate in the clearance of apoptotic cells. In this study, we present evidence that stabilin-1 can function as a receptor involved in the clearance of cell corpses via PS recognition.
Results

Stabilin-1 colocalizes with apoptotic cells in phagosomes
Expression of stabilin-1 by macrophages requires stimulation with IL-4 and dexamethasone. This combination of factors results in the generation of alternatively activated macrophages in vitro. We attempted to determine whether stimulation with IL-4 and dexamethasone can also increase the surface expression of stabilin-1 in human monocyte-derived macrophages (HMDMs) using flow cytometry with an anti-stabilin-1 antibody (N-13). The levels of stabilin-1 on the surface of HMDMs are significantly increased in macrophages stimulated with IL-4 and dexamethasone (IL-4/Dex) (supplementary material Fig. S1 ). Thus the data obtained using a goat N-13 antibody correspond to the data obtained earlier using the MS-1 antibody (Kzhyshkowska et al., 2004) . Therefore, we confirmed that stabilin-1 is exposed on the surface of alternatively activated macrophages. We next investigated the localization of stabilin-1 in macrophages during the engulfment of apoptotic cells. IL-4/Dex-stimulated human macrophages derived from the peripheral blood mononuclear cells (PBMCs) of six healthy donors were used for this assay. Apoptotic Jurkat cells were used as target cells. Apoptotic cells were efficiently internalized by stabilin-1-positive macrophages. Stabilin-1 shows typical partial localization in early endosome antigen 1 (EEA1)-positive endosomes prior to addition of apoptotic cells (Fig. 1A) . After 3 hours of continuous phagocytosis, stabilin-1 was accumulated in the early phagosomes, which were positive for EEA1 (Fig. 1, B-D) . In order to examine the involvement of stabilin-1 on the early stage of recognition and engulfment of apoptotic bodies, we used apoptotic Jurkat cells labeled with the red dye DiD. Confocal microscopy revealed that stabilin-1 is intensively relocalized to the sites of uptake of apoptotic bodies at the early (1 hour) time point of phagocytosis ( Fig. 2 ; supplementary material Fig. S2 ). Z-stack images confirmed that stabilin-1 is localized around the internalized apoptotic Jurkat cells after 3 hours of phagocytosis (supplementary material Fig. S3 ). These data suggest that stabilin-1 might be involved in the clearance of apoptotic cells, specifically during the stage of apoptotic bodyrecognition and during the formation of early phagosomes.
Stabilin-1 is involved in the clearance of aged red blood cells in macrophages
To investigate the involvement of stabilin-1 in the clearance of cell corpses by macrophages, we attempted to determine whether an anti-stabilin-1 antibody that recognizes stabilin-1 on the cell surface inhibits the engulfment of aged red blood cells (RBCs). We selected aged RBCs as a prey because they do not bind to phagocytes without Journal of Cell Science 122 (18) (Kzhyshkowska et al., 2004) . (B-D) Incubation with apoptotic Jurkat cells for 3 hours induced the accumulation of stabilin-1 in early phagosomes, which are positive for EEA1. Stabilin-1 is shown in red, and the early/sorting endosomal marker EEA1 is shown in green. Yellow indicates colocalization of EEA1 and stabilin-1 (merge of green and red). White arrows indicate colocalization of stabilin-1 and EEA-1 (merge of green and red) in phagosomes. Scale bars: 11.35 μm (A), 6.71 μm (B), 9.21 μm (C), and 9.91 μm (D). Stabilin-1 as a phagocytic receptor apoptotic signals, and they allow for the distinction between binding and engulfment via hypotonic lysis (Gigli and Nelson, 1968; Park et al., 2008a) . Confocal microscopy analysis revealed that stabilin-1 is intensively relocalized, presumably to the sites of aged RBC recognition, after 1 hour of aged RBC phagocytosis, and is redistributed to the periphery of phagosomes after 3 hours of aged RBC phagocytosis (supplementary material Fig. S4 ). Active recruitment of stabilin-1 to the sites of recognition and phagosomes during phagocytosis of both apoptotic Jurkat cells and aged RBC was specific, because stabilin-1 was not involved in the phagocytosis of fluorescently labeled microspheres (supplementary material Fig.  S5 ). Pretreatment with an anti-stabilin-1 antibody (N-13) significantly reduced the percentage of HMDMs engulfing aged RBCs (from 32.1±7.1 to 20.1±2.5), whereas an isotype-matched antibody had no effect (from 32.1±7.1 to 32.5±4.4) (Fig. 3A,B) . In unstimulated HMDMs, treatment with anti-stabilin-1 antibody resulted in minimal inhibition of aged RBC engulfment (supplementary material Fig. S6) .
In an effort to further confirm the involvement of stabilin-1 in removal of cell corpses, we designed three short hairpin RNAs (shRNA) that targeted stabilin-1 and cloned them into the pSuper vector. The suppression of stabilin-1 expression was evaluated in CHO-K1 cells by co-transfecting the shRNA-expressing vector along with a stabilin-1-expressing vector. Expression of stabilin-1 was strongly suppressed by pSuper/shRNA-1-2, and to a lesser extent by pSuper/shRNA-1-3, but only marginally by shRNA-1 (Fig.  4A ). In order to effectively suppress the expression of stabilin-1 in macrophages, lentiviruses encoding for stabilin-1 shRNA or its scrambled shRNA, along with green fluorescent protein were prepared (Fig. 4B ). Flow cytometry analysis confirmed that stabilin-1 shRNA and control shRNA have similar transduction efficiencies ( Fig. 4C , right panel). Stabilin-1 shRNA, but not control shRNA, significantly inhibited the expression of the stabilin-1 protein in HMDMs (Fig. 4C, left panel) . In addition, analysis of immunofluorescence staining also revealed that stabilin-1 shRNA effectively downregulates the expression of stabilin-1 in macrophages (Fig. 4D) . The knockdown of stabilin-1 in macrophages caused a decrease in the uptake of aged RBCs (38.7±11.8) as compared to irrelevant knockdown (57.5±7.7) (Fig. 4E) . Collectively, our results demonstrate that stabilin-1 plays a role in the clearance of aged cells in stabilin-1-expressing macrophages.
Stabilin-1 mediated the clearance of aged RBCs in a PSspecific manner
To further examine whether stabilin-1 is involved in the phagocytosis of aged cells, we generated three cell lines that constitutively express stabilin-1 (Fig. 5A ) and examined their phagocytic activity. As expected, stabilin-1-expressing L cells (L/Stab-1) were shown to bind and engulf aged RBCs to a significant degree, whereas L cells transfected with the empty vector (L/Mock) showed little binding to and absolutely no phagocytosis of aged RBCs (Fig. 5B,C) . The uptake of aged RBCs was significantly inhibited by treatment with stabilin-1 shRNA, which resulted in a decrease in stabilin-1 expression levels ( Fig. 5D-F ). This result further demonstrates that stabilin-1 mediates the binding and engulfment of aged cells. Next, in order to investigate whether stabilin-1-mediated phagocytosis is dependent on PS, a molecule which has been identified and well-characterized as an engulfment ligand, we evaluated the engulfment of aged RBCs by L/Stab-1 Fig. 2 . Stabilin-1 is recruited to the sites of apoptotic cell recognition and engulfment in human macrophages. Apoptotic Jurkat cells were added for 1 hour to human macrophages for phagocytosis. Stabilin-1 is shown in red, and apoptotic bodies are shown in blue. Pink indicates colocalization of an apoptotic body with stabilin-1 (merge of red and blue). Scale bars: 6 μm (upper panels) and 9.85 μm (lower panels). 
PS directly interacts with stabilin-1 and is sufficient for stabilin-1-mediated phagocytosis
Stabilin-1 is a type I membrane protein consisting of a signal sequence and extracellular, transmembrane and cytoplasmic regions ( Fig. 7A ) (reviewed by Kzhyshkowska et al., 2006a) . To examine whether stabilin-1 directly interacts with PS, we expressed the recombinant protein corresponding to the extracellular region of stabilin-1 as an Fc-fusion protein (Stab1-Fc) (Fig. 7A) . We also generated PS-coated beads to mimic apoptotic cells and rule out any possible binding via other molecules on the apoptotic cell surface. Coating with PS on the bead surface was quantified by the binding of FITC-labeled annexin V. PS-coated beads acquired the ability to bind annexin V (Fig. 7B) . When beads coated with phospholipids were incubated with Stab1-Fc, PS-coated beads, but not PC-coated beads, bound significantly to Stab1-Fc proteins (Fig.  7C) . These results suggest that stabilin-1 can directly recognize PS exposed on apoptotic cells as an engulfment signal.
We then conducted cell-based phagocytosis assays using beads coated with phospholipids (PC or PS) in order to directly assess the role of stabilin-1 as a PS-receptor involved in the binding and engulfment of apoptotic cells. L cells stably expressing stabilin-1 (L/Stab-1) preferentially bound to PS-coated beads relative to PCcoated beads, whereas L cells transfected with the empty vector (L/Mock) showed only basal levels of binding to either PC-or PScoated beads (Fig. 7D) . PS-coated beads, but not PC-coated beads, were effectively engulfed by L/Stab-1 cells (Fig. 7E) . None of the beads were engulfed by L/Mock cells. These results indicate that PS alone is sufficient to mediate the tethering or engulfment of apoptotic cells by stabilin-1, suggesting that stabilin-1 is a candidate PS-receptor for cell-corpse clearance.
EGF-like domain repeat is involved in PS recognition and binding
In order to further evaluate the PS-binding domain within the extracellular region of stabilin-1, we next generated recombinant proteins of the sixth FAS1 domain (FAS1-6) and the third EGFlike domain repeat (EGFrp-3) and then examined their effects on the activity of binding to apoptotic Jurkat cells. EGFrp-3 protein bound to apoptotic cells in a dose-dependent manner, whereas FAS1-6 protein did not (Fig. 8A) . We also examined whether EGFrp-3 protein directly binds to PS using PC-and PS-coated beads. In agreement with the results using apoptotic cells, EGFrp-3 protein significantly bound to PS-coated beads but not PC-coated beads. FAS1-6 protein did not bind to either PS-or PC-coated beads (Fig.  8B) . These results indicate that EGFrp in stabilin-1 is responsible for PS recognition and binding. Although stabilin-2 plays a crucial role in clearance of cell corpses in HMDMs, the role of stabilin-2 in alternatively activated macrophages is unknown. We examined the surface expression of stabilin-2 in HMDMs stimulated with IL-4/Dex via flow cytometry using a monoclonal anti-stabilin-1 antibody (5G3). Alternatively activated macrophages showed the expression of stabilin-2 to the same degree as observed in IL-4/Dex-unstimulated macrophages (Fig. 9A) . Next, we investigated the phagocytic activity of stabilin-2 in IL-4/Dex-stimulated or IL-4/Dex-unstimulated HMDMs using function-blocking antibody. Pretreatment of anti-stabilin-2 antibody inhibited the engulfment of aged RBCs in IL-4/Dex-stimulated macrophages, which was similar to what was observed in IL-4/Dexunstimulated macrophages (Fig. 9B) . These results showed that stabilin-2 expresses in HMDMs regardless of activation conditions and also plays a role in cell-corpse clearance in alternatively activated macrophages.
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Discussion
Stabilin-1 is a multifunctional receptor that mediates endocytosis of extracellular soluble factors such as acLDL and SPARC, as well as intracellular sorting of cargo proteins such as lysosomal protein SI-CLP (Kzhyshkowska et al., 2006b; Kzhyshkowska et al., 2006c; Tamura et al., 2003) . However, the characterization of stabilin-1 as a membrane receptor has been controversial for some time because previous histological data has indicated its predominant localization in intracellular vesicles in both macrophages and sinusoidal endothelial cells (Kzhyshkowska et al., 2004) . The expression of stabilin-1 can be induced by treatment of peripheral blood-derived monocytes with a combination of IL-4 and dexamethasone. In this study, we have confirmed that surface expression of stabilin-1 was also upregulated by combination of IL-4 and dexamethasone. This type of monocyte stimulation represents a well-established, in vitro model of alternative macrophage activation (M2) (Goerdt et al., 1993; Gordon, 2003; Kodelja et al., 1997; Politz et al., 2002) . Alternatively activated macrophages actively participate in antiinflammatory and healing processes and display high phagocytic activity . A recent study showed that IL-10-producing macrophages (M2) preferentially clear early apoptotic cells (Xu et al., 2006) . In addition, we have demonstrated that stabilin-2, which is highly homologous to stabilin-1, is a PS receptor that mediates the engulfment of apoptotic cells (Park et al., 2008a) . On the basis of these findings, we hypothesized that stabilin-1 in macrophages could also be involved in the clearance of apoptotic and aged cells.
Four lines of evidence bolster the claim that stabilin-1 mediates the clearance of apoptotic cells in alternatively activated macrophages. First, stabilin-1 is recruited to the sites of recognition and engulfment of apoptotic bodies and colocalizes with phagocytosed apoptotic bodies in early phagosomes. Second, the blockade of stabilin-1 with shRNA or blocking antibody resulted in reduced uptake of aged RBCs in HMDMs. Third, stabilin-1-expressing cells were shown to mediate the binding and engulfment of aged RBCs in a PS-specific manner, and this engulfment activity was inhibited significantly by stabilin-1-specific shRNA. Fourth, a substantial portion of the PS-coated beads, but not the PC-coated beads, were bound and engulfed by stabilin-1-expressing cells. EGFrp in stabilin-1 directly binds to PS-coated beads, thereby suggesting that stabilin-1 might function as a receptor that potentially binds directly to PS via its EGFrps. Taken together, our results indicate that stabilin-1 performs an important function as a membrane receptor for clearance of cell corpses in macrophages.
Stabilin-1 is involved in two traffic pathways in human macrophages. The first is early endocytosis and recycling, and the second is trafficking between the endosomal system and the biosynthetic Golgi compartment (Kzhyshkowska et al., 2006a) . In addition to acting as a scavenger receptor for acLDL and SPARC, we demonstrated that stabilin-1 mediates the clearance of apoptotic and aged cells and is recruited to the sites of apoptotic cell recognition and engulfment in macrophages. The engulfment of apoptotic cells by phagocytes leads to actin polymerization and to the extension of membrane protrusions to form a closed phagosome. Membrane delivery is considered to play an important role in pseudopodia extension during phagocytosis (Huynh et al., 2007) . Considering the fact that stabilin-1 is a rapidly recycled receptor localized in intracellular vesicle, membrane targeting of stabilin-1-containing vesicles might act as a source for 'membrane delivery'. Stabilin-1 is also involved in intracellular sorting and in secretion of a novel chitinase-like protein, SI-CLP, and hormone placental lactogen, indicating that stabilin-1 is involved in the delivery of both newly synthesized and endocytosed proteins to distinct secretory pathways (Kzhyshkowska et al., 2008; Journal of Cell Science 122 (18) . 9 . Stabilin-2 is also involved in cell-corpse clearance in alternatively activated macrophages. (A) Surface expression of stabilin-2 in macrophages stimulated with IL-4/Dex. HMDMs were grown with (+) or without (-) IL-4/Dex for six days followed by incubation with monoclonal anti-stabilin-2 antibody (5G3) or isotype-matched antibody (Isotype Ab). Next, the cells were washed, incubated with Alexa-Fluor-488-conjugated secondary antibody for 45 minutes on ice, and processed for FACS analysis. Isotype-matched antibody was used as control. Three independent experiments were performed and a representative image is shown. (B) Stabilin-2 is also involved in the clearance of aged RBCs in alternatively activated macrophages. HMDMs were pretreated with anti-stabilin-2 or an isotype-matched antibody prior to the addition of aged RBCs. Phagocytosis assays were conducted, and the percentages of macrophages that harbored aged RBCs were determined. The results are expressed as the means ± s.d. from three independent experiments. ANOVA: *P<0.05. Stabilin-1 as a phagocytic receptor al., 2006b). There is growing evidence that active immunosuppressive and anti-inflammatory responses can be induced by phagocytes that bind and ingest apoptotic cells. Therefore, it is possible that the clearance of apoptotic cells by stabilin-1 might change the secretory repertoire of a macrophage via the induction or inhibition of its function as a sorting receptor.
Stabilin-1 and stabilin-2 are multifunctional receptors with a similar domain structure. Nevertheless, the function of stabilin-1 appears to be significantly different from stabilin-2, and the only ligand shared by stabilin-1 and stabilin-2 is acLDL. We previously showed that stabilin-2-mediated phagocytosis is partially inhibited by acLDL (data not shown), suggesting that an apoptotic cell is another common ligand of stabilin-1 and stabilin-2. Although stabilin-1 and stabilin-2 share similar expression in sinusoidal endothelial cells of spleen, liver and lymph node, and in our alternatively activated HMDM model, they show a different expression pattern in macrophages. Firstly, stabilin-1-positive macrophages are found in many tissues including placenta, skin, colon and lymph node (Kzhyshkowska et al., 2006a; Martens et al., 2006) , whereas the expression of stabilin-2 is restricted to a few macrophages including alveolar macrophages (data not shown) and HMDMs (Park et al., 2008a) . Secondly, while stabilin-2 is abundant on the cell surface in HMDMs regardless of activation conditions, surface expression of stabilin-1 in macrophages require the stimulation by IL-4 and dexamethasone, suggesting that stabilin-1 acts as a receptor for apoptotic-cell clearance in alternatively activated macrophages. Furthermore, we found that expression of stabilin-1 and stabilin-2 in macrophages is regulated by different transcriptional factors (unpublished data). Thus, it is possible that these receptors are acting in different macrophage populations in different physiological or pathological conditions.
Our results showed that the extracellular region of stabilin-1 directly interacts with PS-coated beads but not PC-coated beads. We also observed that the coating of beads with PS induced their uptake by stabilin-1, suggesting that PS alone is a sufficient signal for phagocytosis mediated by stabilin-1. Recently, we demonstrated that the EGFrp of stabilin-2 recognizes PS during cell-corpse clearance and that at least four EGF-like domains containing an atypical EGF-like domain and calcium are required for PS recognition (Park et al., 2008c) . In this study, we found that stabilin-1 also mediates PS recognition via its EGFrps. Furthermore, our recent study showed that GULP/CED-6 (PTB domain-containing engulfment adaptor protein 1/cell death protein 6) is involved in stabilin-2-mediated phagocytosis, and that its phosphotyrosinebinding (PTB) domain is able to specifically interact with one specific NPXY motif in the stabilin-2 cytoplasmic tail (Park et al., 2008b) . GULP/CED-6 contains the PTB domain, which is known to interact with the NPXY/F motif (Calderwood et al., 2003; Su et al., 2002) . Considering that stabilin-1 contains a NPXF motif in its cytoplasmic tail, stabilin-1-mediated phagocytosis might also operate via intracellular signal transduction pathways similar to those for stabilin-2.
The blockade of stabilin-1 receptor with shRNA or blocking antibody resulted in a partial reduction of aged-cell engulfment. This could be due to significant redundancy in cell-corpse recognition by using several receptors of HMDM at the same time. Current studies showed that the transmembrane receptors Tim4 (Miyanishi et al., 2007) , BAI1 and stabilin-2 might serve as PS-receptors that are involved in cell-corpse clearance. Although we have showed that stabilin-2 is also involved in aged-cell engulfment in our alternatively activated HMDM model, there is still no evidence to indicate whether Tim4 and BAI1 are involved in apoptotic cell phagocytosis in alternatively activated macrophages. Whether stabilin-1 and stabilin-2 are functionally linked or act independently is also unclear at present. However, the results of this study provide evidence that stabilin-1 is a receptor for the clearance of aged and apoptotic cells, particularly in alternatively activated macrophages. Our results should help elucidate the molecular mechanism by which apoptotic cell clearance occurs in the human body, and by which PS is recognized during many physiological and pathological conditions.
Materials and Methods
Reagents
Normal goat IgG and rabbit IgG were obtained from Chemicon. For immunofluorescent analysis, a rabbit polyclonal anti-stabilin-1 antibody (RS1) was used as previously described (Kzhyshkowska et al., 2008) . For fluorescence-activated cell sorting (FACS) analysis and function blocking, a goat polyclonal anti-stabilin-1 antibody (N-13) was purchased from Santa Cruz Biotechnology. The anti-EEA1 mouse monoclonal antibody was from BD Biosciences. A monoclonal antibody recognizing the FLAG epitope (clone M2) was obtained from Sigma. Monoclonal anti-stabilin-2 antibody (5G3) was used as previously described (Park et al., 2008a) . Alexa-Fluor-488-conjugated anti-goat IgG antibody and Alexa-Fluor-568-conjugated anti-rabbit IgG were obtained from Molecular Probes. Anti-human IgG and horseradish peroxidase (HRP)-conjugated anti-His antibody were purchased from Santa Cruz Biotechnology. Polybrene was acquired from Sigma. NBD-PC (1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine), NBD-PS (1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phospho-L-serine) and all phospholipids were purchased from Avanti-Polar Lipids (Alabaster, AL).
Cell culture
Human monocytes were obtained from normal donors, isolated using monocyte isolation kit II systems (Milteny Biotec, Bergisch Gladbach, Germany) and cultured in X-vivo 10 (BioWhittaker, Walkersville, MD) containing 10% human serum. The cells were stimulated with the combination of IL-4 at 10 ng/ml (R&D Systems) and dexamethasone at 100 nM (Sigma). The differentiated macrophages (HMDMs) were utilized after 7-10 days of culturing. Alternatively, stabilin-1-positive macrophages were produced in the absence of serum as previously described (Kzhyshkowska et al., 2008) . HEK293 cells were grown in Dulbecco's modified Eagle's medium (DMEM) (high glucose) containing 10% fetal bovine serum (FBS). Jurkat T cells were maintained in Roswell Park Memorial Institute (RPMI)-1640 culture medium containing 10% FBS.
Stable transfection
Mouse fibroblasts L cells (ATCC CCL-1), kindly donated by Masatoshi Takeichi (Kyoto University, Japan), were grown in DMEM supplemented with 10% heatinactivated FBS and the appropriate antibiotics. The complete stabilin-1 cDNA was amplified from the KG-1 cell line and cloned into pcDNA(+) 3.1 (Invitrogen) with the FLAG epitope sequence. L cells were transfected in OptiMEM I medium using Lipofectamine (Invitrogen). For stable transfection, L cells were selected in G418 (400 μg/ml). Individual G418-resistant colonies were isolated after 10-12 days of culture. The final clones were designated L/Stab-1-#. Negative control clones were randomly selected following transfection with empty vector (L/Mock). The expression of stabilin-1 was analyzed by western blot or flow cytometry.
Fluorescence-activated cell sorting (FACS) analysis
For the analysis of surface staining, the cells were incubated with 1 μg/ml of antistabilin-1 antibody (N-13) on ice for 30 minutes with gentle agitation every 5 minutes. The cells were washed twice, resuspended in phosphate-buffered saline (PBS), and incubated with 4 μg/ml of Alexa-Fluor-488-conjugated anti-goat secondary antibody for 45 minutes on ice. After three washes with PBS, the cells were resuspended in PBS, and then analyzed via flow cytometry on a FACScalibur cytometer (BD Biosciences).
Binding and phagocytosis of aged red blood cells
Aged RBCs were prepared by incubating cells in PBS (20% hematocrit) at 37°C for 4 days as previously described (Oka et al., 1998; Park et al., 2008a) . Exposure of PS on the surface of aged RBCs was detected using annexin-V-fluorescein isothiocyanate (FITC) and an Annexin V Apoptosis detection kit (Santa Cruz Biotechnology). Next, aged RBCs were added to the transfected L cells or HMDMs and then incubated for 1-2 hours at 37°C. After washing away the unbound RBCs, the uningested RBCs were lysed by adding deionized H 2 O for 10 seconds followed by immediate replacement with DMEM, as previously described (Ogden et al., 2001) . The cells were then fixed with methanol and stained using a Diff Quick staining kit (IMEB, San Marcos, CA). Binding and phagocytosis of aged RBCs were quantified via light microscopy prior to and following hypotonic lysis, respectively. The percentages of binding and phagocytosis were determined on the basis of the percentages of phagocytes that were positive for binding and engulfment, respectively, as described previously (Park et al., 2008b; Park et al., 2008c) . At least 100 cells were scored per well, and all experiments were repeated at least three times. In certain experiments, the phagocytosis assay was performed in the presence of an anti-stabilin-1 antibody or anti-stabilin-2 antibody (5G3). Isotype-matched antibody was used as control. Aged RBCs were labeled with FITC prior to their addition to HMDMs. In experiments using phospholipid liposomes, phospholipid liposomes were pre-incubated with L/Stab-1 cells for 1 hour at 37°C prior to the addition of aged RBC.
Phagocytosis of apoptotic cells
Apoptosis in Jurkat cells was induced by exposure to UV irradiation at 254 nm 300 J/cm² in a UV-Gel-Crosslinker/Stratalinker and further maintained for 6 hours or 16 hours. Apoptosis was assessed by morphology using light microscopy. After 6 hours, over 80% of cells were apoptotic. After 16 hours, all cells were apoptotic. Both 6-hour and 16-hour apoptotic cells were used in phagocytosis assay with similar results. In order to visualize apoptotic cells using a confocal microscope, Jurkat cells were labeled with Vybrant DiD (Molecular Probes) prior to induction of apoptosis. Apoptotic cells were added to macrophages at a ratio of 10:1. Phagocytosis was allowed to take place for 1 or 3 hours. Then, fixation and immunofluorescence analysis were performed as previously described (Kzhyshkowska et al., 2008) . Confocal microscopy was performed with a Leica TCS SP2 laser scanning spectral confocal microscope, equipped with a 63ϫ 1.32 objective. Excitation was with an argon laser emitting at 488 nm, a krypton laser emitting at 568 nm, and a helium-neon laser emitting at 633 nm. Data were acquired and analyzed using Leica Confocal software. All two-color images were acquired using a sequential scan mode.
Lentivirus-mediated shRNA production
Three 20-nt shRNA sequences from three different parts of the human stabilin-1 gene (GenBank accession no. NM_015136) were designed. Candidate oligonucleotides were synthesized and cloned into the pSuper/basic vector (OligoEngine, Seattle, WA). Effective shRNA vectors were selected by co-transfection with a vector expressing stabilin-1 in CHO-K1 cells; pSuper/shStab-1-2 significantly downregulated the expression of the stabilin-1 protein. The expression cassette of pSuper/shStab-1-2 was subcloned into the pRNAT-U6.1/Lenti lentiviral vector (GenScript, Piscataway, NJ). Scrambled shRNA (shCont) was used as a control for stabilin-1 shRNA (shStab-1). All constructs were confirmed via sequence analysis. Lentiviral transduction was conducted in accordance with the manufacturer's instructions (GenScript). Briefly, the pRNAT-shStab-1 vector was co-transfected with the packaging vector (Invitrogen) into 293FT cells (Invitrogen). The supernatant was collected after 72 hours and filtered through a 0.22 μm pore acetate filter. HMDMs were seeded at 2ϫ10 5 cell/ml into six-well plates. Lentiviral particles and 8 μg/ml of polybrene (Sigma) were added to the culture. In our system utilizing lentivirus-mediated-shRNA, the depletion of stabilin-1 via shRNA-mediated gene silencing was determined to be effective 3 days after infection. pRNAT-shStab-1 and pRNAT-shCont vectors also harbored the transgene for green fluorescent protein (GFP), allowing for the monitoring of infection efficiency.
Immunofluorescence staining and confocal microscopy
HMDMs were infected with a lentivirus harboring either shStab-1 or shCont (irrelevant knockdown). At 72 hours post-infection, the cells were fixed in 4% formaldehyde in PBS for 15 minutes at room temperature and then permeabilized with 0.1% Triton X-100. Nonspecific binding was minimized by incubating the cells in PBS containing 2% bovine serum albumin (BSA) for 1 hour. After three washes with PBS, the slides were incubated for 1 hour at room temperature with a polyclonal anti-stabilin-1 antibody or rabbit IgG as an isotype-matched control. The slides were washed three times for 5 minutes each with PBS at room temperature. Alexa-Fluor-568-conjugated anti-rabbit IgG (Molecular Probes) was added and then incubated for 1 hour at room temperature. The slides were washed three times with PBS for 5 minutes each time and treated with a solution of SlowFade (Molecular Probes). The slides were viewed with a Zeiss light microscope using Axioplan2 imaging.
Liposome preparation
Liposomes containing the indicated phospholipid and phosphatidylcholine at a molar ratio of 50:50 were prepared. The lipids were mixed in chloroform and then dried under nitrogen gas. Next, the dried lipids were resuspended in PBS at a final concentration of 5 mM, followed by sonication for 10 minutes on ice.
Preparation of phospholipid-coated beads
The coating of beads with lipids was performed as previously described (Yeung et al., 2006) . Briefly, Nucleosil 120-5 C18 beads (5 μm; Richard Scientific, Novato, CA) were dissolved in chloroform and either DOPC or a mixture of PC:PS (80:20 mol%) was added before the mixture was dried under nitrogen. The beads were rehydrated with PBS and briefly sonicated before use.
Preparation of recombinant protein in mammalian cells and binding assays
To generate an expression vector for Stab1-Fc fusion protein, the cDNA encoding for the immunoglobulin Fc region was amplified by PCR, cloned into pcDNA3.1(+) (Invitrogen), and designated as pcDNA-Fc. Next, the cDNA corresponding to the extracellular region of stabilin-1 (amino acids 1-2476) was amplified from a fulllength stabilin-1 cDNA by PCR, cloned into pcDNA-Fc vector, and designated as pcDNA-Stab1-Fc. HEK293T cells were then transfected with the pcDNA-Stab1-Fc vector for 6 hours using Lipofectamine (Invitrogen), in accordance with the manufacturer's instructions. At 24 hours after transfection, the culture medium was exchanged with serum-free DMEM. The supernatant was collected after 48 hours and incubated with PS-or PC-coated beads at 4°C for 4 hours in the presence of 5 mM CaCl 2 . The beads were then washed three times with PBS (pH 7.4). The precipitated proteins were dissociated by boiling in SDS-sample buffer and subjected to SDS-PAGE on a 6% gel. The bound Stab1-Fc proteins were detected via immunoblotting with anti-human IgG (Santa Cruz Biotechnology).
Binding and phagocytosis of PS-coated beads
Phospholipid-coated beads were labeled with PC-NBD and added to L/Stab-1 cells. After 2 hours of incubation, the non-ingested beads were removed by extensive washing. In order to further identify the engulfed cells, fluorescence derived from bound beads (remnant beads) was quenched using trypan blue as previously described (Park et al., 2008a) . The binding and uptake of phospholipid-coated beads was quantified via light microscopy prior to and following trypan blue quenching, respectively. The binding index was determined by calculating the number of bound beads per cell. The percentage of phagocytosis was determined by calculating the percentage of phagocytes positive for engulfment.
